Detalhe da pesquisa
1.
Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
Clin Infect Dis
; 60(11): 1715-21, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25737374
2.
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
J Antimicrob Chemother
; 70(7): 2084-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25885327
3.
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
Microbiol Spectr
; 11(1): e0326722, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692300
4.
Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.
EBioMedicine
; 41: 455-464, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803934
5.
A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level.
Open Forum Infect Dis
; 4(2): ofx064, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28584850
6.
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
PLoS One
; 8(7): e69144, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874894